Bessemer Group
ANGO icon

Bessemer Group’s AngioDynamics ANGO Stock Holding History

Bessemer Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Hold
180
– – ﹤0.01% 2378
2026
Q1 		$2K Sell
180
-2
-1% -$22 ﹤0.01% 2345
2025
Q4 		$2K Hold
182
– – ﹤0.01% 2385
2025
Q3 		$2K Buy
182
+2
+1% +$19 ﹤0.01% 2288
2025
Q2 		$2K Hold
180
– – ﹤0.01% 2174
2025
Q1 		$2K Sell
180
-15
-8% -$158 ﹤0.01% 2202
2024
Q4 		$2K Hold
195
– – ﹤0.01% 2181
2024
Q3 		$2K Buy
+195
New +$1.41K ﹤0.01% 2161
2023
Q4 		– Sell
-352
Closed -$3K – 2132
2023
Q3 		$3K Buy
+352
New +$2.93K ﹤0.01% 1831
2020
Q3 		– Sell
-94,300
Closed -$959K – 1347
2020
Q2 		$959K Hold
94,300
– – ﹤0.01% 805
2020
Q1 		$984K Sell
94,300
-14,500
-13% -$182K ﹤0.01% 612
2019
Q4 		$1.74M Sell
108,800
-2,100
-2% -$32.1K 0.01% 604
2019
Q3 		$2.04M Buy
110,900
+11,000
+11% +$215K 0.01% 514
2019
Q2 		$1.97M Buy
99,900
+1,900
+2% +$38.7K 0.01% 537
2019
Q1 		$2.24M Buy
98,000
+23,717
+32% +$515K 0.01% 427
2018
Q4 		$1.5M Buy
74,283
+31,687
+74% +$656K 0.01% 474
2018
Q3 		$926K Sell
42,596
-9,404
-18% -$209K ﹤0.01% 599
2018
Q2 		$1.16M Hold
52,000
– – ﹤0.01% 541
2018
Q1 		$897K Hold
52,000
– – ﹤0.01% 610
2017
Q4 		$865K Sell
52,000
-11,200
-18% -$191K ﹤0.01% 650
2017
Q3 		$1.08M Buy
63,200
+7,700
+14% +$129K ﹤0.01% 632
2017
Q2 		$900K Buy
55,500
+2,100
+4% +$33.2K ﹤0.01% 701
2017
Q1 		$926K Buy
53,400
+3,700
+7% +$61.9K ﹤0.01% 731
2016
Q4 		$838K Buy
49,700
+12,700
+34% +$212K ﹤0.01% 765
2016
Q3 		$649K Buy
+37,000
New +$600K ﹤0.01% 702

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bessemer Group's ANGO Position: Q2 2026 in Review

Bessemer Group held its AngioDynamics (ANGO) position steady in Q2 2026 at 180 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2378.

Bessemer Group first reported a position in ANGO in Q3 2016 and has held it in 25 quarters since. The position peaked at $2.24M in Q1 2019. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Bessemer Group held 180 shares of AngioDynamics worth $2K as of Q2 2026.
  • Bessemer Group left its AngioDynamics share count unchanged in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2378 holding.
  • Bessemer Group first reported a position in AngioDynamics in Q3 2016 and has held it in 25 quarters since.
  • Bessemer Group's AngioDynamics position peaked at $2.24M in Q1 2019.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.